Page last updated: 2024-09-03

5-methoxy-6-methyl-2-aminoindan and 3-hydroxybenzylhydrazine

5-methoxy-6-methyl-2-aminoindan has been researched along with 3-hydroxybenzylhydrazine in 1 studies

Compound Research Comparison

Studies
(5-methoxy-6-methyl-2-aminoindan)
Trials
(5-methoxy-6-methyl-2-aminoindan)
Recent Studies (post-2010)
(5-methoxy-6-methyl-2-aminoindan)
Studies
(3-hydroxybenzylhydrazine)
Trials
(3-hydroxybenzylhydrazine)
Recent Studies (post-2010) (3-hydroxybenzylhydrazine)
1300273016

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, X; Nichols, DE1

Other Studies

1 other study(ies) available for 5-methoxy-6-methyl-2-aminoindan and 3-hydroxybenzylhydrazine

ArticleYear
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
    European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1993